Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

2(33.3%)

6Total

N/A(4)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06579469Recruiting

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Role: collaborator

NCT06182163Not ApplicableCompleted

Reduce Sedentary Time in Acute Lymphoblastic Leukemia

Role: collaborator

NCT05106296Phase 1Recruiting

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Role: collaborator

NCT07019259Not ApplicableRecruiting

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Role: collaborator

NCT04968834Recruiting

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Role: collaborator

NCT06722638Not ApplicableRecruiting

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

Role: collaborator

NCT02457845Phase 1Completed

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Role: collaborator

NCT03603886Not ApplicableCompleted

Adolescent Cancer Telemedicine for Pain Management

Role: collaborator

All 8 trials loaded